• High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
  • High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
  • High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
  • High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
  • High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
  • High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0

High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0

Function: Antibiotic and Antimicrobial Agents
Certification: GMP
Grade Standard: Medicine Grade
Type: Analysis reagent
State: Solid
Volatile: Not Volatile
Samples:
US$ 0/g 1 g(Min.Order)
| Request Sample
Customization:
Gold Member Since 2019

Suppliers with verified business licenses

Trading Company

Basic Info.

Model NO.
BP/USP
CAS
873945-29-0
Assay
99.5%
Transport Package
25kg/Drum
Specification
USP/BP
Trademark
SINOAH
Origin
China
HS Code
3003101100
Production Capacity
5mt/Month

Product Description

High Purity and Good Price Marbofloxacin CAS 873945-29-0  Made in China
 

Marbofloxacin Manufacturer CAS 115550-35-1 with Purity 99% Pharmaceutical Chemicals

Basic information
CAS No:115550-35-1                              
MF: C17H19FN4O4                                    Einecs No.:N/a
Appearance:Light yellow powder           Grade Standard:Medicine Grade
Usage:Animal Pharmaceuticals               Shelf Life:2 Year

MARBOFLOXACIN CAS 115550-35-1

Property: Light Yellow Crystalline Powder,New type of animal dedicated fluoroquinolone drugs. Marbofloxacin is a new type of fluoroquinolone antibiotic, by inhibiting bacterial DNA transcription to inhibit the growth of bacteria, the gram-negative bacteria, gram-positive bacteria and mycoplasma have antibacterial activity. Ma Bo effect through oral and injected drugs were able to absorb good, low toxic and side effect.

Pharmacokinetics: absorption was rapid and complete after administration and injection, plasma protein binding rate was low, tissue distribution was wide, and it was well distributed in kidney, liver, lung and skin. The oral bioavailability of pregnant sows and cats was about 80%, and that of calves was more than 100%. All the tissue concentrations detected were higher than those in plasma. Some of them were metabolized into inactive metabolites such as N-demethylation MBF and N-oxygen MBF in the liver. The main excretion pathway was the kidney, and the canine excreted 3045% of the prototype drug in urine. Intramuscular injection and subcutaneous administration of fowl (intramuscular injection), broiler (intramuscular injection), sows (intramuscular injection) were 4.33, 5.265.74 and 10 h, respectively, and the effective blood concentration was maintained for a longer period of time after intramuscular injection and subcutaneous injection, respectively, for 14 h and 13 h.

Application: Fluoroquinolone antibiotic, used for treatment of deep and superficial skin infection, urinary tract infection, the cat's skin and soft tissue infection, acute upper respiratory tract infection. Used for sensitive bacteria caused by cattle, pigs, dogs, cats, respiratory tract, the digestive tract, urinary tract, skin infections, etc. For cattle, sheep mastitis mastitis and pigs - metritis - no milk syndrome are malignant.

Use:Used for sensitive bacteria caused by cattle, pigs, dogs, cats, respiratory tract, the digestive tract, urinary tract, skin infections, etc. For cattle, sheep mastitis mastitis and pigs - metritis - no milk syndrome are malignant.


Specification: 

   (ITEMS )

      ( STANDARDS )

Appearance

        Light yellowish Crystalline powder

       Solubility

Water

        Slightly soluble

 

        Sparingly soluble

Ethanol (96%)

        Very slightly soluble

Identification -IR Spectrum

Concordant with the spectrum of    reference substance

         Absorbance

           ≤0.20

        Related substances (%)

Impurity C, D, E

           ≤0.2%

Impurity A, B

           ≤0.1%

Unspecified Impurities

           ≤0.2%

Total Impurity

            ≤0.5%

Heavy metal

≤20ppm

Loss on drying

             ≤0.5%

Sulphated ash

             ≤0.10%

Assay(on the dried basis):

          99.0%-101.0%


High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0
High Purity Pharmaceutical Raw Material Marbofloxacin CAS: 873945-29-0



 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now